Anders Pedersen Email

Head Clinical Development . Nerviano Medical Sciences - Part of NMS Group

Current Roles

Employees:
95
Revenue:
$9.7M
About
Nerviano Medical Sciences is part of NMS Group and it is focused on the discovery and early development of oncology drugs. Our business model is to partner our drugs at late preclinical or early clinical stage for full development and commercialization. Our mission is to pursue innovative therapeutic approaches in Oncology, discovering and developing molecules with novel mechanisms of action, for the advancement of personalized care of cancer patients. An experienced and lean management team leads a highly skilled staff of professionals with international experience and a broad range of expertise in R&D, combining the flexibility of a biotech with the quality standards of a big pharma.
Nerviano Medical Sciences - Part of NMS Group Address
501 Boylston Street
NERVIANO, Mi
Nerviano Medical Sciences - Part of NMS Group Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.